Author: GlobeNewswire

Company Announcement COPENHAGEN, Denmark; July 06, 2021 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 47,974 shares…

Accelus to Offer Procedure-Enabling Technology with the Goal of Making Minimally Invasive Surgery (MIS) the Standard of Care in SpinePALM…

                 Monthly information related to total number of voting rights and shares composing the share capital – June 30, 2021.…

Company announcement – No. 45/ 2021 ZEALAND PHARMA A/S – TRANSACTIONS UNDER SHARE REPURCHASE PROGRAM Copenhagen 6 July 2021 – On…

Saint-Herblain (France), July 6, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company focused on the…

DURHAM, N.C., July 06, 2021 (GLOBE NEWSWIRE) — CoImmune, Inc., a clinical stage immuno-oncology company that will redefine cancer treatment…

HONG KONG, SHANGHAI and FLORHAM PARK, N.J., July 05, 2021 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:…

VANCOUVER, British Columbia, July 05, 2021 (GLOBE NEWSWIRE) — MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) (“MYM” or the “Company”),…

OSLO, Norway, July 05, 2021 (GLOBE NEWSWIRE) — Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune stimulatory…

Oslo, 5 July 2021: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, today…